Cowen Downgrades Momenta Pharmaceuticals (MNTA) to Neutral
Tweet Send to a FriendGet Alerts MNTA Hot Sheet
Price: $14.45 +0.28%
Rating Summary:
5 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
5 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade MNTA Now!
Cowen downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Outperform to Neutral.
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $12.30 yesterday, with a 52 week range of $11.91-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $12.30 yesterday, with a 52 week range of $11.91-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- Baird Downgrades Sonoco Products (SON) to Neutral
- KeyBanc Downgrades Sanderson Farms (SAFM) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
